VERTEX PHARMACEUTICALS INC / MA Finance Lease, Liability
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Finance Lease, Liability of $112.20 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiability · last filed 2026-02-13
- 2025-12-31: Finance Lease, Liability $112.20M.
- 2024-12-31: Finance Lease, Liability $118.00M.
- 2024-09-30: Finance Lease, Liability $119.10M.
- 2023-12-31: Finance Lease, Liability $426.70M.
| Period end | Finance Lease, Liability | Finance Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $112.20M 10-K · filed 2026-02-13 | |
| 2024-12-31 | $118.00M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $119.10M 10-Q · filed 2024-11-05 | |
| 2023-12-31 | $426.70M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $471.60M 10-K · filed 2024-02-15 | |
| 2021-12-31 | $556.70M 10-K · filed 2023-02-10 | |
| 2020-12-31 | $581.50M 10-K · filed 2022-02-09 | $581.48M 10-K · filed 2021-02-11 |
| 2019-12-31 | $577.37M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $578.62M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $588.58M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $596.11M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $596.64M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |